The effect of 5-Aminolevulinic Acid to diagnose the upper urinary tract tumor with retrograde intra-renal ureteroscopy

The effect of 5-Aminolevulinic Acid to diagnose the upper urinary tract tumor with retrograde intra-renal ureteroscopy - ALADER STUDY

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035166

Enrollment

Registered

2018-12-08

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper tract urinary tumor UTUC

Interventions

preoperative oral medicine of 5ALA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The following are inclusion criteria a, suspect of UTUC for imaging study(CT, MRI, IVP, RP) and negative urinary cytology b, suspect of UTUC for negative bladder tumor and positive urinary cytology c, Undergoing ureteroscopic treatment for UTUC

Exclusion criteria

Exclusion criteria: The following are exclusion criteria 1) patient with positive imaging finding and positive urinary cytology 2) patient with porphyrine allegery 3) patient with 5ALA allegery

Design outcomes

Primary

Measure	Time frame
Sensitivity	—

Secondary

Measure	Time frame
Specifity	—

Countries

Japan

Contacts

Public ContactTAKASHI YOSHIDA

Kansai Medical University Urology and Surgery

yoshidtk@takii.kmu.ac.jp81-06-6992-1001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026